Concepedia

Publication | Closed Access

Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn’s Disease

37

Citations

20

References

2022

Year

Abstract

In this real-world cohort of highly refractory CD patients, upadacitinib was effective in inducing remission and had an acceptable safety profile.

References

YearCitations

Page 1